leadf
logo-loader
viewCardiex Ltd

CardieX appoints CFO and company secretary Jarrod White as a company director

The company’s devices, technologies and digital solutions enable better management of global health disorders around cardiovascular health and hypertension.

Cardiex Ltd - Cardiex Ltd appoints Jarrod White to director of the company
CardieX is a global health technology company that develops digital and device-based solutions for large-scale population health disorders

Cardiex Ltd (ASX:CDX) has appointed Sydney-based CFO and company secretary Jarrod White as a director of the company, effective immediately.

This comes after the board identified the practical issues and restrictions imposed on international travel during the COVID-19 pandemic, which affect the ability of directors to travel between Australia, the USA and other countries.

Having an additional Sydney-based director will assist CardieX to be more responsive to the local business’ needs and requirements and will enhance the board’s capacity as the company grows its presence, product range and revenue internationally in the coming months and years.

Appointment strengthens board

White has been the chief financial officer and company secretary of CardieX since early 2018.

While continuing in both roles, with Philip Leighfield’s appointment as joint company secretary, White’s appointment as a director is also recognition of this significant contribution over the last two years.

CardieX chairman Niall Cairns said: “This is a sensible appointment by the board particularly during the current economic climate and Jarrod’s credentials as an experienced Chartered Accountant will strengthen the board’s capacity during a time of growth and change for the company.”

Substantial holder interest changes

Meantime, substantial holder Paul Cozzi has increased his stake in the company to 14.58% from 12.96% with the change occurring on May 7.

On that date, Sydney-based Cozzi acquired 11.9 million shares valued at approximately $250,000 and he now holds more than 109.5 million shares.

Quick facts: Cardiex Ltd

Price: 0.054 AUD

ASX:CDX
Market: ASX
Market Cap: $45.24 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Cardiex Ltd named herein, including the promotion by the Company of Cardiex Ltd in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

CardieX Limited signs disruptive deal with Chinese medical device company Andon

CardieX Limited (ASX: CDX) CEO Craig Cooper joined Steve Darling from Proactive with news the company has entered a co-development and commercial partnership agreement with Andon. Andon is one of China’s largest manufacturers of home-use medical electronic devices. Cooper talks about the deal...

on 9/9/20

2 min read